Mylan is recalling two lots of levoleucovorin injection, a chemotherapy drug, because copper salts were found in the samples during a 12-month stability testing.
Pfizer’s Hospira plant is recalling three lots of a sodium bicarbonate injection after glass particles were discovered in some vials.
Neither company has received reports of adverse events related to the recall.
“Administration of a sterile injectable that has foreign particulates has the potential of severe health consequences,” Mylan said in the recall notice.
Both companies have notified their direct customers.
More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry
